Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cerilliant
Healthtrust
US Department of Justice
Express Scripts
Deloitte
Covington
Moodys
Chinese Patent Office
Boehringer Ingelheim

Generated: August 17, 2017

DrugPatentWatch Database Preview

POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES Drug Profile

« Back to Dashboard

What is the patent landscape for Polyethylene Glycol 3350 And Electrolytes, and what generic Polyethylene Glycol 3350 And Electrolytes alternatives are available?

Polyethylene Glycol 3350 And Electrolytes is a drug marketed by Paddock Llc and is included in one NDA.

The generic ingredient in POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.

Summary for Tradename: POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list105,536
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
FOR SOLUTION;ORAL090712-001Feb 25, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Farmers Insurance
US Department of Justice
Colorcon
Medtronic
QuintilesIMS
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot